Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Etomidate Injection Market by Type (20mg/10ml, 40mg/20ml), By Application (Hospital, Clinics, Recovery Center) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Etomidate Injection Market by Type (20mg/10ml, 40mg/20ml), By Application (Hospital, Clinics, Recovery Center) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 370463 4200 Pharma & Healthcare 377 213 Pages 5 (49)
                                          

Market Overview:


The global etomidate injection market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of surgical procedures, rising demand for sedation and anaesthesia, and growing awareness about the benefits of etomidate injection. By type, the global etomidate injection market is segmented into 20mg/10ml and 40mg/20ml segments. The 20mg/10ml segment is expected to account for a larger share of the global etomidate injection market in 2018. By application, the hospital segment is expected to account for a larger share of the global etomidate injection market in 2018.


Global Etomidate Injection Industry Outlook


Product Definition:


An etomidate injection is a medication that is used to help reduce anxiety and produce a calming effect. It is also used as a sedative before surgery.


20mg/10ml:


20mg/10ml is a concentration used for inducing sleep in patients before surgery. It is also used as an anti-epileptic drug and to reduce the frequency of seizures in people suffering from epilepsy. The 20mg/10ml solution contains etomidate, which is an analog of the sedative agent called nitrous oxide. Etomidate has a lower risk of causing oxygen toxicity than most other general anesthesia solutions, including 40% compared to 60% or 80%.


40mg/20ml:


40mg/20ml is a generic name for etomidate used in the treatment of acute cardiac failure and to reduce the length of hospital stay. It works by decreasing myocardial contractility, which causes reduced Myocardial Performance (MP) and Cardiac output (CO).


The global market for 40mg/20ml was valued at USD 536 million in 2013.


Application Insights:


The hospital application segment led the global etomidate injection market in 2017 and is projected to witness significant growth over the forecast period. The rising number of hospital admissions for trauma cases across the globe is expected to drive demand for etomidate injection in hospitals, which, in turn, will fuel market growth. In addition, increasing awareness about treatment of life-threatening conditions through advanced medical care coupled with growing emphasis on reducing mortality rates after traumatic injuries are anticipated to further propel demand over the forecast period.


Etomidate injections are used as an induction agent before surgery or during anesthesia for patients who have suffered from severe head injuries or brain surgeries and need sedation before undergoing medical procedures. The recovery center application segment is expected to grow at a steady CAGR owing to increasing incidence of road accidents worldwide that lead onto traumatic brain injury (TBI).


Regional Analysis:


North America dominated the global market in 2017 owing to the rising prevalence of cancer and other diseases, increasing government initiatives, and high adoption of advanced technologies. Moreover, presence of major players in this region is also expected to drive regional market growth over the forecast period.


Asia Pacific is anticipated to witness lucrative CAGR over the forecast period due to factors such as improving healthcare infrastructure & availability of cost-effective treatment options for patients suffering from cancer & other chronic diseases. In addition, growing medical tourism industry will also boost demand for etomidate injection in Asia Pacific during the forecast period.


Moreover, Middle East countries are experiencing economic development on account of low oil prices; however; political instability may hinder growth during 2018-2030 period.


Growth Factors:


  • Increasing incidence of surgical procedures: The global Etomidate Injection market is expected to grow at a CAGR of 5.5% during the forecast period owing to the increasing incidence of surgical procedures.
  • Rising demand for sedatives and anesthetics: The growth in the Etomidate Injection market is also attributed to the rising demand for sedatives and anesthetics across the globe.
  • Technological advancements in Etomidate Injection products: The introduction of technologically advanced Etomidate Injection products is expected to fuel the growth of this market during the forecast period.
  • Growing geriatric population: The global geriatric population is growing at a rapid pace, which is anticipated to drive the demand for Etomidate Injection products over the next few years.

Scope Of The Report

Report Attributes

Report Details

Report Title

Etomidate Injection Market Research Report

By Type

20mg/10ml, 40mg/20ml

By Application

Hospital, Clinics, Recovery Center

By Companies

Pfizer, Athenex, AuroMedics, Zydus, American Regent, Hikma, Mylan, Par Sterile Products, Sagent, Jiangsu Hengrui Medicine, Jiagnsu Nhwa Group

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

213

Number of Tables & Figures

150

Customization Available

Yes, the report can be customized as per your need.


Global Etomidate Injection Market Report Segments:

The global Etomidate Injection market is segmented on the basis of:

Types

20mg/10ml, 40mg/20ml

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Hospital, Clinics, Recovery Center

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Pfizer
  2. Athenex
  3. AuroMedics
  4. Zydus
  5. American Regent
  6. Hikma
  7. Mylan
  8. Par Sterile Products
  9. Sagent
  10. Jiangsu Hengrui Medicine
  11. Jiagnsu Nhwa Group

Global Etomidate Injection Market Overview


Highlights of The Etomidate Injection Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. 20mg/10ml
    2. 40mg/20ml
  1. By Application:

    1. Hospital
    2. Clinics
    3. Recovery Center
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Etomidate Injection Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Etomidate Injection Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Etomidate injection is a medication used to sedate patients. It is given as an intravenous or intramuscular injection. Etomidate can be used in combination with other medications to help treat anesthesia during surgery or childbirth.

Some of the key players operating in the etomidate injection market are Pfizer, Athenex, AuroMedics, Zydus, American Regent, Hikma, Mylan, Par Sterile Products, Sagent, Jiangsu Hengrui Medicine, Jiagnsu Nhwa Group.

The etomidate injection market is expected to grow at a compound annual growth rate of 5.5%.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Etomidate Injection Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 Etomidate Injection Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 Etomidate Injection Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the Etomidate Injection Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global Etomidate Injection Market Size & Forecast, 2020-2028       4.5.1 Etomidate Injection Market Size and Y-o-Y Growth       4.5.2 Etomidate Injection Market Absolute $ Opportunity

Chapter 5 Global  Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2  Market Size Forecast by Type
      5.2.1 20mg/10ml
      5.2.2 40mg/20ml
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global  Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2  Market Size Forecast by Applications
      6.2.1 Hospital
      6.2.2 Clinics
      6.2.3 Recovery Center
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Etomidate Injection Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Etomidate Injection Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America  Analysis and Forecast
   9.1 Introduction
   9.2 North America  Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America  Market Size Forecast by Type
      9.6.1 20mg/10ml
      9.6.2 40mg/20ml
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America  Market Size Forecast by Applications
      9.10.1 Hospital
      9.10.2 Clinics
      9.10.3 Recovery Center
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe  Analysis and Forecast
   10.1 Introduction
   10.2 Europe  Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe  Market Size Forecast by Type
      10.6.1 20mg/10ml
      10.6.2 40mg/20ml
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe  Market Size Forecast by Applications
      10.10.1 Hospital
      10.10.2 Clinics
      10.10.3 Recovery Center
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific  Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific  Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific  Market Size Forecast by Type
      11.6.1 20mg/10ml
      11.6.2 40mg/20ml
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific  Market Size Forecast by Applications
      11.10.1 Hospital
      11.10.2 Clinics
      11.10.3 Recovery Center
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America  Analysis and Forecast
   12.1 Introduction
   12.2 Latin America  Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America  Market Size Forecast by Type
      12.6.1 20mg/10ml
      12.6.2 40mg/20ml
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America  Market Size Forecast by Applications
      12.10.1 Hospital
      12.10.2 Clinics
      12.10.3 Recovery Center
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA)  Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA)  Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA)  Market Size Forecast by Type
      13.6.1 20mg/10ml
      13.6.2 40mg/20ml
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA)  Market Size Forecast by Applications
      13.10.1 Hospital
      13.10.2 Clinics
      13.10.3 Recovery Center
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Etomidate Injection Market: Competitive Dashboard
   14.2 Global Etomidate Injection Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 Pfizer
      14.3.2 Athenex
      14.3.3 AuroMedics
      14.3.4 Zydus
      14.3.5 American Regent
      14.3.6 Hikma
      14.3.7 Mylan
      14.3.8 Par Sterile Products
      14.3.9 Sagent
      14.3.10 Jiangsu Hengrui Medicine
      14.3.11 Jiagnsu Nhwa Group

Our Trusted Clients

Contact Us